{"entity":{"type":"insider","cik":"0001816477","url":"/insider/0001816477","json_url":"/insider/0001816477.json","name":"Del Carmen Jeffrey","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2022-08-22","last":"2025-11-28","span_basis":"filed_date"},"name_variants":[{"name":"Del Carmen Jeffrey","source":"filing","n_filings":7,"first_seen":"2022-08-22","last_seen":"2025-11-28"}],"transactions":[{"id":4878988,"accession":"0001161697-25-000430","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001161697-25-000430","line_url":"/filing/0001161697-25-000430#line-2","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001816477","owner_name":"Del Carmen Jeffrey","owner_display_name":"Del Carmen Jeffrey","owner_url":"/insider/0001816477","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10983.0,"shares_display":"10,983","price_per_share":23.331,"price_display":"23.33","price_state":"stated","total_value":256244.373,"total_display":"256,244.37","total_whole":"256,244","shares_owned_after":3962.0,"shares_owned_after_display":"3,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-26","filed_date":"2025-11-28","scope":"insider"},{"id":5068823,"accession":"0001161697-25-000084","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-25-000084","line_url":"/filing/0001161697-25-000084#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001816477","owner_name":"Del Carmen Jeffrey","owner_display_name":"Del Carmen Jeffrey","owner_url":"/insider/0001816477","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30423.0,"shares_display":"30,423","price_per_share":22.89,"price_display":"22.89","price_state":"stated","total_value":696382.47,"total_display":"696,382.47","total_whole":"696,382","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-03","filed_date":"2025-03-05","scope":"insider"},{"id":3131770,"accession":"0001161697-24-000341","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001161697-24-000341","line_url":"/filing/0001161697-24-000341","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001816477","owner_name":"Del Carmen Jeffrey","owner_display_name":"Del Carmen Jeffrey","owner_url":"/insider/0001816477","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36058.0,"shares_display":"36,058","price_per_share":18.423360141993456,"price_display":"18.42","price_state":"stated","total_value":664309.52,"total_display":"664,309.52","total_whole":"664,310","shares_owned_after":12369.0,"shares_owned_after_display":"12,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-09","filed_date":"2024-08-13","scope":"insider","n_lines":2},{"id":3217694,"accession":"0001161697-24-000262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-24-000262","line_url":"/filing/0001161697-24-000262#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001816477","owner_name":"Del Carmen Jeffrey","owner_display_name":"Del Carmen Jeffrey","owner_url":"/insider/0001816477","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7541.0,"shares_display":"7,541","price_per_share":16.07,"price_display":"16.07","price_state":"stated","total_value":121183.87,"total_display":"121,183.87","total_whole":"121,184","shares_owned_after":18427.0,"shares_owned_after_display":"18,427","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-07","filed_date":"2024-06-11","scope":"insider"},{"id":7828615,"accession":"0001161697-23-000201","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-23-000201","line_url":"/filing/0001161697-23-000201","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001816477","owner_name":"Del Carmen Jeffrey","owner_display_name":"Del Carmen Jeffrey","owner_url":"/insider/0001816477","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":16.69524575,"price_display":"16.70","price_state":"stated","total_value":667809.83,"total_display":"667,809.83","total_whole":"667,810","shares_owned_after":7541.0,"shares_owned_after_display":"7,541","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-29","filed_date":"2023-03-30","scope":"insider","n_lines":2},{"id":6506990,"accession":"0001161697-22-000547","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001161697-22-000547","line_url":"/filing/0001161697-22-000547","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001816477","owner_name":"Del Carmen Jeffrey","owner_display_name":"Del Carmen Jeffrey","owner_url":"/insider/0001816477","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":139017.0,"shares_display":"139,017","price_per_share":16.123077299898572,"price_display":"16.12","price_state":"stated","total_value":2241381.837,"total_display":"2,241,381.84","total_whole":"2,241,382","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-15","scope":"insider","n_lines":2},{"id":6175639,"accession":"0001161697-22-000405","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001161697-22-000405","line_url":"/filing/0001161697-22-000405#line-1","is_derivative":false,"issuer_cik":"0001369568","issuer_name":"CATALYST PHARMACEUTICALS, INC.","issuer_ticker":"CPRX","issuer_name_source":null,"issuer_url":"/issuer/0001369568","owner_cik":"0001816477","owner_name":"Del Carmen Jeffrey","owner_display_name":"Del Carmen Jeffrey","owner_url":"/insider/0001816477","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14140.0,"shares_display":"14,140","price_per_share":14.05,"price_display":"14.05","price_state":"stated","total_value":198667.0,"total_display":"198,667.00","total_whole":"198,667","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-19","filed_date":"2022-08-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001369568","name":"CATALYST PHARMACEUTICALS, INC.","url":"/issuer/0001369568","role":"Officer (Chief Commercial Officer)","n_filings":7,"first_seen":"2022-08-22","last_seen":"2025-11-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001816477","retrieved_at":"2026-08-27T13:33:57+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}